<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d609">
    <sentence id="DDI-DrugBank.d609.s0" text="An inhibitor of CYP2C8 (such as gemfibrozil) may increase the AUC of rosiglitazone and an inducer of CYP2C8 (such as rifampin) may decrease the AUC of rosiglitazone. ">
        <entity id="DDI-DrugBank.d609.s0.e0" charOffset="32-42"
            type="drug" text="gemfibrozil"/>
        <entity id="DDI-DrugBank.d609.s0.e1" charOffset="69-81"
            type="drug" text="rosiglitazone"/>
        <entity id="DDI-DrugBank.d609.s0.e2" charOffset="117-124"
            type="drug" text="rifampin"/>
        <entity id="DDI-DrugBank.d609.s0.e3" charOffset="151-163"
            type="drug" text="rosiglitazone"/>
        <pair id="DDI-DrugBank.d609.s0.p0" e1="DDI-DrugBank.d609.s0.e0"
            e2="DDI-DrugBank.d609.s0.e1" ddi="true" type="mechanism"/>
        <pair id="DDI-DrugBank.d609.s0.p1" e1="DDI-DrugBank.d609.s0.e0"
            e2="DDI-DrugBank.d609.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d609.s0.p2" e1="DDI-DrugBank.d609.s0.e0"
            e2="DDI-DrugBank.d609.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d609.s0.p3" e1="DDI-DrugBank.d609.s0.e1"
            e2="DDI-DrugBank.d609.s0.e2" ddi="false"/>
        <pair id="DDI-DrugBank.d609.s0.p4" e1="DDI-DrugBank.d609.s0.e1"
            e2="DDI-DrugBank.d609.s0.e3" ddi="false"/>
        <pair id="DDI-DrugBank.d609.s0.p5" e1="DDI-DrugBank.d609.s0.e2"
            e2="DDI-DrugBank.d609.s0.e3" ddi="true" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d609.s1" text="Therefore, if an inhibitor or an inducer of CYP2C8 is started or stopped during treatment with rosiglitazone, changes in diabetes treatment may be needed based upon clinical response.">
        <entity id="DDI-DrugBank.d609.s1.e0" charOffset="95-107"
            type="drug" text="rosiglitazone"/>
    </sentence>
</document>
